Clinical Trials
3 trialsNCT05557903 2022-09-28
Phase â… Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL
Lanzhou Institute of Biological Products Co., Ltd
Phase 1 Unknown
NCT00077961 2015-03-26
Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL
Sanofi
Phase 1/2 Terminated
NCT00051701 2015-03-05
Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma
Sanofi
Phase 1/2 Terminated